Xia Li is a Principal Pharmacometrician at Johnson & Johnson Innovative Medicine, where they apply Model-Informed Drug Development (MIDD) to support dose selection for drug development. They have extensive experience in population pharmacokinetics (pop PK) and physiologically-based pharmacokinetics (PBPK), having developed various models and conducted analyses throughout their career. Previously, Xia worked as a Research Scientist in pharmacometrics at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on PK/PD modeling and simulation for oncology. They earned a Ph.D. in Pharmacology from Universität zu Köln and hold multiple degrees in pharmacy and medicinal chemistry from Soochow University and Freie Universität Berlin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices